I. Durieu

9.6k citations
233 papers · 4.8k · 1 hit paper · h-index 34

Impact in

    • Venous Thromboembolism Diagnosis and Management
    • Cystic Fibrosis Research Advances
    • Neonatal Respiratory Health Research
    • Tracheal and airway disorders
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers in

I. Durieu

217 papers receiving 4.6k citations

I. Durieu's Hit Papers

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease 2021 · 153 citations
1530+1+3Years since publication50100150

Peers

I. Durieu
Comparison fields: 5 of 118
  • Internal Medicine 296
  • Pulmonary and Respiratory Medicine 1.7k
  • Hematology 557
  • Epidemiology 867
  • Rheumatology 380
Replace Armin Grau with:
Armin Grau Germany
Lorenzo Dagna Italy
Peter J. Conlon Ireland
Alastair Windsor United Kingdom
H. Hirche Germany
Peter F. Hoyer Germany
Rudolf Speich Switzerland
Florian Buggle Germany
Ioannis E. Κoutroubakis Greece
Isabelle Tillie‐Leblond France
I. Durieu relative to Armin Grau Germany Armin Grau's profile →
Citations per field
00.5×2×3.5×
Armin Grau · 1×
Citations per year

Countries citing papers authored by I. Durieu

Since Specialization
Citations

This map shows the geographic impact of I. Durieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Durieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Durieu more than expected).

Fields of papers citing papers by I. Durieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Durieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Durieu. The network helps show where I. Durieu may publish in the future.

Co-authors

The 25 scholars most cited alongside I. Durieu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I. Durieu Line = papers co-authored together I. Durieu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 233 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2001305
2 2001274
3 2014198
4 2014182
5
Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease
Hit paper breakdown →
2021153
6 2002140
7 2013138
8 1999137
9 2015133
10 2014101
11 201997
12 201897
13 200793
14 201481
15 200373
16 200369
17 201967
18 199967
19 199862
20 200459

About I. Durieu

I. Durieu is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Surgery, Rheumatology and Hematology, having authored 233 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (83 papers), Neonatal Respiratory Health Research (12 papers), Tracheal and airway disorders (10 papers), Antifungal resistance and susceptibility (10 papers), Systemic Lupus Erythematosus Research (9 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Autoimmune and Inflammatory Disorders Research (7 papers) and Vasculitis and related conditions (6 papers). The work is most often cited by research in Internal Medicine (296 citations), Pulmonary and Respiratory Medicine (1.7k citations), Hematology (557 citations), Epidemiology (867 citations) and Rheumatology (380 citations). I. Durieu has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Quitterie Reynaud, Jean‐Christophe Lega, Didier Leys, Florence Pasquier, Hilde Hénon, S. Durupt, Florence Lebert, J. Ninet, Nicole Fabien and Vincent Cottin. Their work appears in journals such as Journal of Cystic Fibrosis, Medicine, Pediatric Pulmonology, Journal of Clinical Medicine and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact